Amelia S. Petry
- Infectious Diseases top 5%
- Virology top 5%
- Epidemiology
- Pediatrics, Perinatology and Child Health
- Hepatology top 10%
- Co-authors
- John A. WagnerJulie A. StoneLarissa WenningMarian IwamotoKeith GottesdienerEric ManginWilliam D. HanleyKalyan Ghosh
- Topics
- HIV/AIDS drug development and treatment (8 papers)HIV Research and Treatment (5 papers)Pharmacological Effects and Toxicity Studies (3 papers)
- Partner nations
- United StatesNew Zealand
In The Last Decade
Amelia S. Petry
9 papers receiving 410 citations
Peers
Comparison fields: 5 of 35
- Infectious Diseases 367
- Virology 209
- Epidemiology 119
- Pediatrics, Perinatology and Child Health 78
- Hepatology 64
Countries citing papers authored by Amelia S. Petry
This map shows the geographic impact of Amelia S. Petry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amelia S. Petry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amelia S. Petry more than expected).
Fields of papers citing papers by Amelia S. Petry
This network shows the impact of papers produced by Amelia S. Petry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amelia S. Petry. The network helps show where Amelia S. Petry may publish in the future.
Co-authorship network of co-authors of Amelia S. Petry
This figure shows the co-authorship network connecting the top 25 collaborators of Amelia S. Petry. A scholar is included among the top collaborators of Amelia S. Petry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amelia S. Petry. Amelia S. Petry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 29 | |
| 3 | Safety and Antiviral Activity of MK-5172, a Novel HCV NS3/4a Protease Inhibitor with Potent Activity Against Known Resistance Mutants, in Genotype 1 and 3 HCV-Infected Patients | 27 |
| 4 | 37 | |
| 5 | 127 | |
| 6 | Raltegravir (RAL) Pharmacokinetics in Individuals with UGT1A1*1/*1 and UGT1A1*28/*28 Genotypes | 2 |
| 7 | 74 | |
| 8 | 53 | |
| 9 | 70 |
About Amelia S. Petry
Amelia S. Petry is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 9 papers that have together received 423 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). The work is most often cited by research in Virology (209 citations), Infectious Diseases (367 citations) and Hepatology (64 citations). Amelia S. Petry has collaborated with scholars based in United States and New Zealand. Frequent co-authors include John A. Wagner, Julie A. Stone, Larissa Wenning, Marian Iwamoto, Keith Gottesdiener, Eric Mangin, William D. Hanley, Kalyan Ghosh, Diana M. Brainard and Sheila Breidinger. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.